You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Details for Patent: 4,423,041


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,423,041
Title: Detackifying compositions
Abstract:A detackifying composition for use in emulsion-type personal care compositions comprising a mixture of a silicone fluid and a silicone wax in a ratio of from about 9:l to 1:3.
Inventor(s): Clum; Charles E. (Kingston, NJ), Felty; Lanny G. (Pine Grove, PA)
Assignee: Johnson & Johnson Products, Inc. (New Brunswick, NJ)
Application Number:06/278,283
Patent Claim Types:
see list of patent claims
Composition; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 4,423,041

Introduction

United States Patent 4,423,041, titled "Detackifying Composition for Use in Emulsion-Type Personal Care Compositions," was granted on December 27, 1983. This patent, assigned to Ethicon, Inc., introduces a novel composition designed to reduce the tackiness of personal care products. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Inventors and Assignee

The patent was invented by Clum et al. and assigned to Ethicon, Inc., a company known for its medical and consumer products[4].

Background and Motivation

The invention addresses the ongoing need for effective detackifying systems in emulsion-type personal care compositions. Prior art disclosed various compositions, but they often had limitations in terms of efficacy and stability. The inventors aimed to create a composition that would significantly reduce tackiness while maintaining the desired properties of the personal care products.

Claims Analysis

Independent Claims

The patent includes several claims, with the independent claims defining the core of the invention. Here is a summary of the key independent claim:

  • Claim 1: A detackifying composition for use in emulsion-type personal care compositions, comprising a mixture of a silicone fluid and a silicone wax in a specific ratio (9:1 to 1:3 by weight)[4].

Dependent Claims

Dependent claims further specify the invention by adding additional limitations or features. For example:

  • Claim 2: The composition of claim 1, wherein the silicone fluid is a polydimethylsiloxane and the silicone wax is a polyethylene-polydimethylsiloxane copolymer[4].

Scope of the Invention

Composition Details

The patented composition consists of a mixture of a silicone fluid and a silicone wax. The specific ratio of these components is crucial, ranging from 9:1 to 1:3 by weight. This ratio ensures the effective reduction of tackiness in emulsion-type personal care products.

Applications

The detackifying composition is designed for use in various personal care products, including creams, lotions, and gels. These products are commonly used in both consumer and medical settings.

Prior Art and References

Cited Patents and Publications

The patent references several prior art documents, including U.S. patents and foreign patent documents. For example:

  • U.S. Pat. No. 2,798,053 and U.S. Pat. No. 3,133,865 are cited as relevant prior art in the field of personal care compositions[4].

Technological Context

The invention builds upon existing knowledge in the field of silicone-based formulations. The use of silicone fluids and waxes in personal care products was not new, but the specific combination and ratio disclosed in this patent provided a novel solution to the problem of tackiness.

Patent Landscape

Related Patents

Several patents related to detackifying compositions and personal care products have been filed and granted both before and after U.S. Patent 4,423,041. For instance:

  • U.S. Pat. No. 5,972,358, granted in 1999, describes a mixture of silicone wax, silicone fluid, and lactate molecules for reducing tackiness in topical formulations. This patent shows the ongoing development in the field of detackifying systems[4].

International Patent Databases

To understand the global patent landscape, one can refer to international patent databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO). These databases offer insights into similar inventions filed in other jurisdictions[1].

Economic and Legal Implications

Presumption of Validity

Each claim of the patent is presumed valid independently of the validity of other claims, as per 35 USC 282. This presumption can be challenged through various legal defenses, but it provides a strong foundation for the patent holder's rights[5].

Licensing and Litigation

The patent's validity and scope can impact licensing agreements and potential litigation. Companies interested in using similar compositions must either obtain a license or ensure their products do not infringe on the patented claims.

Conclusion

United States Patent 4,423,041 represents a significant innovation in the field of personal care products by providing an effective detackifying composition. The detailed analysis of its claims and scope highlights the importance of precise ratios of silicone fluid and wax. Understanding the broader patent landscape and prior art is crucial for companies operating in this sector to navigate intellectual property rights and potential legal challenges.

Key Takeaways

  • Composition: The patent describes a mixture of silicone fluid and silicone wax in a specific ratio.
  • Applications: The composition is used in emulsion-type personal care products like creams, lotions, and gels.
  • Prior Art: The invention builds upon existing knowledge in silicone-based formulations.
  • Patent Landscape: The patent is part of a larger landscape of related patents and international filings.
  • Legal Implications: Each claim is presumed valid, and the patent's scope can impact licensing and litigation.

FAQs

  1. What is the main claim of U.S. Patent 4,423,041?

    • The main claim is for a detackifying composition comprising a mixture of a silicone fluid and a silicone wax in a specific ratio (9:1 to 1:3 by weight).
  2. What are the primary applications of the patented composition?

    • The composition is primarily used in emulsion-type personal care products such as creams, lotions, and gels.
  3. How does this patent build upon prior art?

    • The patent builds upon existing knowledge in silicone-based formulations by introducing a novel ratio of silicone fluid and wax that effectively reduces tackiness.
  4. What international databases can be used to search for related patents?

    • Databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO) can be used to search for related patents.
  5. What is the legal presumption regarding the validity of the patent claims?

    • Each claim of the patent is presumed valid independently of the validity of other claims, as per 35 USC 282.

Sources

  1. USPTO - Search for patents

  2. ACUS - U.S. Patent Small Claims Court

  3. USPTO - Patent Claims Research Dataset

  4. United States Patent - 4,423,041

  5. 35 USC 282: Presumption of validity; defenses

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,423,041

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.